Form 8-K - Current report:
SEC Accession No. 0001683168-20-000599
Filing Date
2020-02-27
Accepted
2020-02-27 16:00:10
Documents
2
Period of Report
2020-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sonoma_8k.htm 8-K 19116
2 ASSET PURCHASE AGREEMENT sonoma_ex1001.htm EX-10.1 118091
  Complete submission text file 0001683168-20-000599.txt   138412
Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 20661845
SIC: 2834 Pharmaceutical Preparations